|Bid||0.0000 x 1000|
|Ask||0.0000 x 900|
|Day's range||1.6800 - 1.9000|
|52-week range||0.6000 - 2.1500|
|Beta (5Y monthly)||1.73|
|PE ratio (TTM)||N/A|
|Earnings date||05 May 2021 - 10 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.75|
This call contains forward-looking statements regarding trends, strategies, and anticipated performance of the Castlight business, including, but not limited to, guidance for 2021, new sales, our ability to bring new innovation, the opportunities and impact of COVID on our own operations, our ability to sell and our operating results, opportunities and the impact of COVID on our customers, businesses and their decisions to buy certain benefits or institute workforce reductions, retention of existing customers, gross margin and operating cash expense trends, cash used, future cash position and the changes in the growth strategy on the company's performance. As any of these risks or uncertainties develop or if any one of assumptions prove incorrect, actual results could differ materially from those expressed or implied by our forward-looking statements.
SAN FRANCISCO (AP) _ Castlight Health Inc. (CSLT) on Tuesday reported a loss of $1.2 million in its fourth quarter. On a per-share basis, the San Francisco-based company said it had a loss of 1 cent. Earnings, adjusted for stock option expense and non-recurring costs, were 2 cents per share. The online health care software company posted revenue of $37.1 million in the period.
Veeva (VEEV) collaborates with Impel to accelerate the pre-launch planning and digital-first commercial execution for migraine treatment.